Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study

• JINNAI Itsuro

  Department of Health Evaluation, Ogawa Red Cross Hospital

• SAKURA Tohru

  Department of Hematology, Maebashi Saiseikai Hospital

• TSUZUKI Motohiro

  Department of Internal Medicine, Fujita Health University School of Medicine

• MAEDA Yasuhiro

  Division of Hematology, Kinki University School of Medicine

• USUI Noriko

  Department of Clinical Oncology and Hematology, Jikei University School of Medicine

• KATO Masayuki

  Division of Hematology and Oncology, St. Marianna University School of Medicine

• OKUMURA Hirokazu

  Department of Hematology, Kanazawa University Graduate School of Medical Science

• KYO Taiichi

  Department of 4th Internal Medicine, Hiroshima Red Cross Hospital

• UEDA Yasunori

  Department of Hematology/Oncology, Kurashiki Central Hospital

• KISHIMOTO Yuji

  Department of Hematology, Kansai Medical University

• YAGASAKI Fumiharu

  Department of Hematology, International Medical Center, Saitama Medical University

• TSUBOI Kosuke

  Department of Hematology/Oncology, Tokai University School of Medicine

• HORIIKE Shigeo

  Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine

• TAKEUCHI Jin

  Department of Hematology and Rheumatology, Nihon University School of Medicine

• IWANAGA Masako

  Department of Molecular Medicine and Hematology, Nagasaki University Graduate School of Biomedical Sciences

• MIYAZAKI Yasushi

  Department of Molecular Medicine and Hematology, Nagasaki University Graduate School of Biomedical Sciences

• MIYAWAKI Shuichi

  Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital

• OHNISHI Kazunori

  Department of Internal Medicine III, Hamamatsu University School of Medicine

• NAOE Tomoki

  Department of Hematology/Oncology, Nagoya University Graduate School of Medicine

• OHNO Ryuzo

  Aichi Shukutoku University

Journal

• Int J Hematol

  Int J Hematol 92 (3), 490-502, 2010-10-15

Keywords

• Acute lymphoblastic leukemia
• A multiinstitutional trial
• Doxorubicin
• Prognostic factors
• The Japan Adult Leukemia Study Group (JALSG)

Details

• CRID: 1573105976067115008
• NII Article ID: 10027673560
• NII Book ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2011192180
• Text Lang: en
• Data Source:
  • CiNii Articles